JANX - Janux Therapeutics GAAP EPS of -$0.39 beats by $0.10 revenue of $2.85M beats by $2.04M March, 10 2023 04:37 PM Janux Therapeutics Inc. 2023-03-10 16:37:09 ET Janux Therapeutics press release ( NASDAQ: JANX ): Q4 GAAP EPS of -$0.39 beats by $0.10 . Revenue of $2.85M (+75.9% Y/Y) beats by $2.04M . For further details see: Janux Therapeutics GAAP EPS of -$0.39 beats by $0.10, revenue of $2.85M beats by $2.04M